Scottish Medicines Consortium accepts PROSTAP® SR DCS & PROSTAP® 3 DCS (leuprorelin acetate) to treat early and advanced breast cancer[1] [2] London, UK – 8 February 2021, Takeda is pleased to ...
The FINANCIAL — Takeda Pharmaceutical Company Limited ("Takeda") on March 23 announced that it has signed an agreement with Wyeth for the product licence for Prostap (leuprorelin acetate), an LH-RH ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results